Forte Biosciences, Inc.
FBRXDelisted Aug 27, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001419041
Forte Biosciences, Inc. was delisted on Aug 27, 2026; its insiders filed their last Form 4 on Aug 27, 2026; 86 institutions reported holding it in 13F filings for Q2 2026, worth $432.7M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Forte Biosciences, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 62 | 75 | +13 |
| Shares | 7.97M | 8.61M | +641.2K (+8.0%) |
| Value | $273.1M | $289.4M | +$16.3M (+6.0%) |
New holders (31)
Institutions that held Forte Biosciences, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (18)
Institutions that held Forte Biosciences, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| OrbiMed Advisors LLC | 159,664 | $5.47M |
| Altium Capital Management LP | 134,542 | $4.61M |
| Susquehanna International Group, LLP | 52,546 | $1.80M |
| ExodusPoint Capital Management, LP | 45,019 | $1.54M |
| Granite Point Capital Management, L.P. | 44,000 | $1.51M |
| Renaissance Technologies LLC | 39,434 | $1.35M |
| HRT Financial LP | 31,738 | $1.09M |
| California Public Employees Retirement System | 18,000 | $617.0K |
| Squarepoint Ops LLC | 11,586 | $397.0K |
| Schonfeld Strategic Advisors LLC | 10,152 | $347.0K |
| Sepio Capital, LP | 9,526 | $326.0K |
| Transcend Wealth Collective, LLC | 8,000 | $274.0K |
| LMR Partners LLP | 6,540 | $224.0K |
| Bridgeway Capital Management, LLC | 6,319 | $217.0K |
| Virtu Financial LLC | 6,185 | $212.0K |
| Qube Research & Technologies Ltd | 6,129 | $210.0K |
| Meridian Wealth Partners, LLC | 84 | $3.00K |
| Sowell Financial Services LLC | 28 | $1.00K |